Sign in / Join Now
ETFs & Funds
should start getting a lot of serious attention going into 11/29 PDUFA cabozantinib. Priority review.. $
Add a reply...
Latest StockTalks »
people get EXEL breaking news and analysis by email alert.
Get email alerts on EXEL »
Get latest price
From other sites
What's in the Cards for Exelixis (EXEL) in Q2 Earnings?
at Zacks.com (Mon, 10:44AM)
Exelixis Announces Settlement Of Dispute With Genentech Regarding Companies' Collaboration Agreement For Cobimetinib
at TheStreet (Thu, 7:00AM)
Exelixis To Release Second Quarter 2017 Financial Results On Wednesday, August 2, 2017
at TheStreet (Jul 17, 2017)
Why Are Shares of Exelixis (EXEL) Up 77% So Far in 2017?
at Zacks.com (Jul 13, 2017)
Short Interest Decreases By 12.5% For EXEL
at TheStreet (Jul 13, 2017)